Learn to Customize Your Own Options Trading Strategy

From RJO Futures | Ad

This guide will help you evaluate and analyze your trading plan to create a custom options trading strategy tailored to your risk profile and market outlook. Learn how to take your trading to the next level.

Download your FREE Options Strategy Guide Today!

BCDA Insider Trading (BioCardia)

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 22.10%

Insider Buying (Last 12 Months): $19,164.00

Insider Selling (Last 12 Months): $16,954.35

BioCardia Insider Trading History Chart

BioCardia Share Price & Price History

^$3.44

▲ +0.18 (5.52%)

As of 07/28/2021 01:56 PM ET

Days: 30 | 90 | 365

One Stock You Should Watch

From MicroSmallCap | Ad

Tiny stock is straddling not one but two huge markets – read our report to learn more.

Learn more.

BioCardia Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/1/2020	Peter Altman	CEO	Buy	1,000	$2.49	$2,490.00	203,200
11/27/2020	Peter Altman	CEO	Buy	3,200	$2.37	$7,584.00	203,200
11/12/2020	Peter Altman	CEO	Buy	2,000	$2.07	$4,140.00	205,900
11/10/2020	Peter Altman	CEO	Buy	2,500	$1.98	$4,950.00	203,900
11/2/2020	Eric Duckers	Insider	Sell	8,435	$2.01	$16,954.35	12,088
6/19/2020	Jim L Allen	Director	Buy	142,850	$2.10	$299,985.00	668,200
3/24/2020	Peter Altman	CEO	Buy	1,200	$2.90	$3,480.00	171,911
3/19/2020	Peter Altman	CEO	Buy	400	$2.95	$1,180.00	170,711
3/12/2020	Peter Altman	CEO	Buy	3,400	$3.15	$10,710.00	166,811
8/2/2019	Simon H Stertzer	Director	Buy	166,666	$6.00	$999,996.00
6/5/2019	Peter Altman	Insider	Buy	2,000	$1.02	$2,040.00
5/28/2019	Peter Altman	Insider	Buy	200	$1.28	$256.00
5/17/2019	Peter Altman	Insider	Buy	2,100	$1.15	$2,415.00
5/1/2019	Peter Altman	Insider	Buy	11,000	$1.08	$11,880.00
2/13/2019	Peter Altman	Insider	Buy	50	$1.59	$79.50
12/24/2018	Phillip Md Et Al Frost	Major Shareholder	Buy	2,000,000	$0.75	$1,500,000.00
12/24/2018	Simon H Stertzer	Director	Buy	3,333,332	$0.75	$2,499,999.00
11/29/2018	Simon H Stertzer	Director	Buy	1,000	$2.10	$2,100.00
11/16/2018	Peter Altman	Insider	Buy	6,400	$2.34	$14,976.00
11/13/2018	Peter Altman	Insider	Buy	3,900	$2.16	$8,424.00
11/13/2018	Simon H Stertzer	Director	Buy	1,000	$2.10	$2,100.00
11/9/2018	Peter Altman	Insider	Buy	500	$2.50	$1,250.00
11/5/2018	David Mcclung	CFO	Buy	1,600	$2.56	$4,096.00
11/2/2018	Peter Altman	Insider	Buy	400	$2.52	$1,008.00
11/2/2018	Simon H Stertzer	Director	Buy	2,000	$2.53	$5,060.00
10/30/2018	Peter Altman	Insider	Buy	300	$2.55	$765.00
10/26/2018	Peter Altman	Insider	Buy	3,850	$2.36	$9,086.00
10/12/2018	David Mcclung	CFO	Buy	500	$2.64	$1,320.00
10/11/2018	Simon H Stertzer	Director	Buy	1,000	$2.70	$2,700.00
9/25/2018	David Mcclung	CFO	Buy	2,850	$2.45	$6,982.50
9/21/2018	Simon H Stertzer	Director	Buy	1,000	$2.43	$2,430.00
9/20/2018	Peter Altman	Insider	Buy	1,100	$1.74	$1,914.00
9/18/2018	Peter Altman	Insider	Buy	700	$1.59	$1,113.00
9/18/2018	Simon H Stertzer	Director	Buy	5,000	$1.50	$7,500.00
9/12/2018	Peter Altman	Insider	Buy	1,600	$1.37	$2,192.00
9/5/2018	Peter Altman	Insider	Buy	5,000	$1.33	$6,650.00
8/27/2018	Peter Altman	Insider	Buy	1,500	$1.46	$2,190.00

Insider Buying at BioCardia?

Sign-up to receive InsiderTrades.com's daily insider buying and selling report for BioCardia and related companies.

SEC Filings (Institutional Ownership Changes) for BioCardia (NASDAQ:BCDA)

18.57% of BioCardia stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

BioCardia Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/19/2021	Squarepoint Ops LLC	46,945	$0.20M	0.0%	N/A	0.280%
5/13/2021	Renaissance Technologies LLC	305,200	$1.33M	0.0%	N/A	1.817%
5/12/2021	Geode Capital Management LLC	62,168	$0.27M	0.0%	+175.6%	0.370%
5/12/2021	CM Management LLC	313,100	$1.36M	1.0%	+36.1%	1.864%
2/9/2021	Bank of New York Mellon Corp	16,294	$56K	0.0%	N/A	0.131%
2/5/2021	CM Management LLC	230,000	$0.80M	0.7%	N/A	1.851%
8/17/2020	Jane Street Group LLC	14,688	$35K	0.0%	N/A	0.214%
8/14/2020	Captrust Financial Advisors	659,179	$1.62M	0.0%	N/A	9.626%
8/14/2020	Advisor Group Holdings Inc.	85,002	$0.20M	0.0%	-7.7%	1.241%
5/18/2020	Advisor Group Holdings Inc.	92,083	$0.31M	0.0%	N/A	1.349%
11/27/2019	Millennium Management LLC	41,978	$0.14M	0.0%	N/A	0.615%

Data available starting January 2016

BioCardia, Inc., a clinical-stage regenerative medicine company, develops therapeutics for cardiovascular diseases. Its lead therapeutic candidate is the CardiAMP Cell Therapy System for the treatment of heart failure and chronic myocardial ischemia; and ALLOGENEIC cell therapy for cardiac and pulmonary disease. The company is also developing ALLOGENEIC Cell Therapy System, an investigational culture expanded bone marrow derived mesenchymal cell therapy, which is in Phase I/II trial for the treatment of ischemic systolic heart failure. In addition, it offers the Helix biotherapeutic delivery system, a percutaneous catheter delivery system for cardiovascular regenerative medicine; and Morph deflectable guides and sheaths. The company is based in San Carlos, California.

Today's Range

Now: $3.44

$3.44

50 Day Range

MA: $4.05

$3.26

$4.99

52 Week Range

Now: $3.44

$1.91

$8.60

Volume

1 shs

Average Volume

51,543 shs

Market Capitalization

$57.76 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.82

Who are the company insiders with the largest holdings of BioCardia?

BioCardia's top insider investors include:

Jim L Allen (Director)
Peter Altman (CEO)
Eric Duckers (Insider)
Simon H Stertzer (Director)

The Only Futures Trading Guide You’ll Ever Need

From RJO Futures | Ad

Regardless of your level of futures trading prowess, our Technical Analysis Guide has something to help you succeed in today’s futures markets.

Download your FREE Technical Analysis Trading Guide Today!